Moleculin Biotech (MBRX) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-17.02
-11.49
-5.96
-0.43

Details

Expected EPS
-2.333333
Actual EPS
-3.54
Surprise EPS
-1.21
Surprise Percent
+51.71%

Description

Moleculin Biotech (MBRX) has reported earnings of -3.54 per share for Q2 2026.

0 Comments

Share your thoughts